Ormeloxifene is a selective estrogen receptor modulator (SERM) primarily used as an oral contraceptive, as well as for treating dysfunctional uterine bleeding and as an adjuvant therapy for advanced breast… Read more
Ormeloxifene is a selective estrogen receptor modulator (SERM) primarily used as an oral contraceptive, as well as for treating dysfunctional uterine bleeding and as an adjuvant therapy for advanced breast cancer. This category includes high-quality reference standards for ormeloxifene, its hydrochloride salt forms, and relevant stereoisomers such as cis-ormeloxifene. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and stability testing. By utilizing these precisely characterized reference standards and related impurities, analytical chemists can ensure accurate quantitative analysis and regulatory compliance throughout the drug development process. Laboratories also rely on these compounds for the identification of metabolites and the development of stable isotope labelled internal standards, which are critical for robust pharmacokinetic studies and quality control protocols in the evaluation of ormeloxifene-based formulations.